Centre Hospitalier Charles Perrens

Clinical research at this hospital in Bordeaux focuses on mental disorders and broader psychological phenomena, with studies aimed at improving care for people living with complex psychiatric conditions. The work spans treatment evaluation, safety follow-up, and the search for better ways to match care to individual patient profiles.

• Studies on psychotic disorders and autoimmune-related psychiatric symptoms, evaluating whether immunotherapy can improve outcomes alongside standard psychiatric care.
• Long-term safety research in schizophrenia, including follow-up for patients with cognitive impairment after prior treatment participation.
• Research in schizophrenia spectrum disorder examining whether different treatment strategies may work better for specific psychotic phenotypes.

Overall, the site contributes to understanding how precision psychiatry, treatment safety, and symptom-specific care may help improve results for patients with severe mental illness.

Another important area of study at the site is major depressive disorder, with research exploring whether patterns of cerebral neuroinflammation differ between currently affected patients, those in remission, and healthy controls. These trials are designed to improve understanding of the biological processes linked to depression and may support better diagnostic approaches in the future.

• Comparative research in depressive disorder focused on brain inflammation patterns and their possible role in active illness and remission.
• Clinical studies aimed at identifying biological markers that could help distinguish mental disorder subtypes more clearly.

This line of research reflects a growing interest in linking psychiatry with measurable biological signals to better understand mood disorders.

The research portfolio also includes studies in children and adolescents with autism spectrum disorder, especially where irritability and related behavioral symptoms are a concern. These trials are focused on assessing the long-term safety and tolerability of treatment options intended to support younger patients and their families.

• Pediatric research in ASD addressing behavioral symptoms such as irritability and the need for sustained symptom management.
• Safety-focused studies designed to evaluate how well treatments are tolerated over time in children and adolescents.

This work highlights the site’s role in advancing care for younger people with neurodevelopmental and behavioral challenges.